Volume Alert - HIMX 7.50 Himax Technologies $HIMX Hit a

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - HIMX 7.50 Himax Technologies $HIMX Hit a high today of 7.64 Closing the day 10:30 at 7.50 +0.28 +3.88% With a day low of 6.90 and a total volume of 3,252,385.

HIMX Recent Posts: http://investorshangout.com/Himax-Technologie...IMX-54345/

HIMX Himax Technologies Recent Headline News

Himax ticks higher in spite of revenue miss, light guidance
Seeking Alpha - at Seeking Alpha - 1 hr 11 mins ago

HIMX: 7.47 (+0.25)

Himax Technologies EPS in-line, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 4:59AM CST

HIMX: 7.47 (+0.25)

Himax Technologies, Inc. Reports Third Quarter 2014 Financial Results and Provides Fourth Quarter 2014 Guidance
GlobeNewswire - Thu Nov 13, 3:29AM CST
Company meets Q3 revenues, gross margin and EPS guidance
HIMX: 7.47 (+0.25)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 4:30PM CST

KSS: 55.90 (-2.01), VTNR: 5.38 (-0.69), TYC: 41.98 (-1.38), SPH: 44.68 (+0.21), FLY: 12.79 (-0.31), ENZY: 6.89 (+0.22), RWLK: 32.15 (+2.93), WMT: 82.01 (+2.81), RSTI: 25.37 (+2.36), SBH: 30.12 (+0.75), HP: 79.58 (-5.98), GIB: 35.64 (+0.78), TDG: 193.39 (+7.05), CLFD: 13.14 (-0.76), HIMX: 7.47 (+0.25), VIAB: 72.15 (+2.90), MMS: 50.47 (+0.14)

Himax Technologies Shares Down 15.8% Since SmarTrend's Sell Call (HIMX)
Comtex SmarTrend(R) - Wed Nov 12, 9:30AM CST
SmarTrend identified a Downtrend for Himax Technologies (NASDAQ:HIMX) on October 13th, 2014 at $8.57. In approximately 1 month, Himax Technologies has returned 15.75% as of today's recent price of $7.22.
HIMX: 7.47 (+0.25)

TowerJazz Remains On Track And Undervalued
Jaret Wilson - Seeking Alpha - Wed Nov 12, 4:50AM CST
On August 26th, I discussed a number of factors that have left TowerJazz (NASDAQ: TSEM ) extremely underpriced, including a joint venture with Panasonic, cost cutting measures, strong business conditions, operational leverage, and more. Since then...
SWKS: 61.03 (+0.04), IBM: 162.33 (+0.41), MCHP: 43.48 (+0.10), TSEM: 11.14 (+0.72), HIMX: 7.47 (+0.25), RFMD: 13.30 (+0.05)

Look for Shares of Himax Technologies to Potentially Rebound after Yesterday's 5.28% Sell Off
Comtex SmarTrend(R) - Tue Nov 11, 4:44PM CST
Himax Technologies (NASDAQ:HIMX) traded in a range yesterday that spanned from a low of $7.16 to a high of $7.64. Yesterday, the shares fell 5.3%, which took the trading range below the 3-day low of $7.65 on volume of 6.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
HIMX: 7.47 (+0.25)

Why Earnings Season Could Be Great for Himax Technologies (HIMX) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:44AM CST
Investors are always looking for stocks that are poised to beat at earnings season and Himax Technologies, Inc. (HIMX) may be one such company.
HIMX: 7.47 (+0.25)

Will Orbitz Worldwide (OWW) Beat Q3 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 3:00PM CST
We expect Orbitz Worldwide, Inc. (OWW) to beat expectations when it reports third quarter 2014 results on Nov 6.
ZBRA: 71.50 (-0.43), LMOS: 16.97 (+0.20), HIMX: 7.46 (+0.24), OWW: 7.51 (-0.05)

Can Microsemi (MSCC) Surprise This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 5:10PM CST
Microsemi Corporation (MSCC) is slated to report fourth-quarter fiscal 2014 results on Nov 6.
EXPE: 86.65 (-0.46), MSCC: 27.14 (-0.18), HIMX: 7.46 (+0.24), OWW: 7.51 (-0.05)

Why Himax Technologies (HIMX) Stock Might be a Great Pick - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 7:40AM CDT
Himax Technologies is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective
HIMX: 7.46 (+0.24)

Himax Technologies Down 10.0% Since SmarTrend Downtrend Call (HIMX)
Comtex SmarTrend(R) - Wed Oct 29, 9:22AM CDT
SmarTrend identified a Downtrend for Himax Technologies (NASDAQ:HIMX) on October 13th, 2014 at $8.57. In approximately 2 weeks, Himax Technologies has returned 10.04% as of today's recent price of $7.71.
HIMX: 7.46 (+0.24)

Why Himax Technologies (HIMX) Could Be an Impressive Growth Stock - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 7:47AM CDT
Himax Technologies saw EPS growth of 19.4% last year, and might be well-positioned for future earnings growth.
HIMX: 7.46 (+0.24)

Himax Technologies Analyst Valuation and Brief Report: Although Risks Still Remain, Shares Now Trade Closer to Fair Value by BrokerBank Securities, Inc.
PR Newswire - Tue Oct 28, 6:00AM CDT
Innovations in technology have continued to grow at a feverish pace in recent years. Aside from the strong growth in mobile devices such as smartphones and tablets, other innovations such as 4K TVs, LED TVs, 3D TVs, and wearable technologies (Google Glass, smartwatches, etc.) have garnered increasing attention as of late. Among the many companies at the forefront of all these technologies is Himax Technologies, which has grown market share over the years primarily through their market presence in China - where most of the new buildings of panel capacity have taken place.
HIMX: 7.46 (+0.24)

Himax Technologies, Inc. Schedules Third Quarter 2014 Financial Results Conference Call for Thursday, November 13 at 8:00 AM EST
GlobeNewswire - Mon Oct 27, 4:00AM CDT
Himax Technologies, Inc. (Nasdaq:HIMX) ("Himax" or "Company" , a leading supplier and fabless manufacturer of display drivers and other semiconductor products, will hold a conference call with investors and analysts on Thursday, November 13, 2014 at 8:00 a.m. US Eastern Standard Time and 9:00 p.m. Taiwan Time to discuss the Company's third quarter 2014 financial results.
HIMX: 7.46 (+0.24)

Look for Shares of Himax Technologies to Potentially Rebound after Yesterday's 6.11% Sell Off
Comtex SmarTrend(R) - Wed Oct 22, 4:32PM CDT
Himax Technologies (NASDAQ:HIMX) traded in a range yesterday that spanned from a low of $6.75 to a high of $7.88. Yesterday, the shares fell 6.1%, which took the trading range below the 3-day low of $7.80 on volume of 14.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
HIMX: 7.46 (+0.24)

Six Flags and Yahoo are big market movers
AP - Wed Oct 22, 3:26PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:
KO: 42.82 (+0.11), RAI: 65.17 (+0.05), HOG: 67.38 (+0.27), DDD: 33.06 (-1.44), KMB: 114.02 (+0.64), GOOG: 545.00 (-2.31), HOT: 78.57 (+0.66), DFS: 65.42 (-0.59), CMG: 665.53 (+1.28), UIS: 27.34 (-0.56), BDBD: 9.81 (+0.51), GOOGL: 555.71 (-2.54), SIX: 40.51 (-0.36), HIMX: 7.46 (+0.24), AAPL: 112.68 (+1.43)

Himax: Overreaction To Google News Has Resulted In Another Buying Opportunity
Devin D'Angelo - Seeking Alpha - Wed Oct 22, 12:07PM CDT
Tuesday October 21st after the close Himax Technologies (NASDAQ: HIMX ) issued an official press release stating that Google (NASDAQ: GOOG ) declined to exercise their option to increase its investment in HIMX's subsidiary, Himax Display (HDI)....
GOOGL: 555.71 (-2.54), HIMX: 7.46 (+0.24), GOOG: 545.00 (-2.31)

3 Reasons To Buy Himax After Another Plunge
Chris Lau - at Seeking Alpha - Wed Oct 22, 11:04AM CDT

GOOGL: 555.71 (-2.54), HIMX: 7.46 (+0.24), GOOG: 545.00 (-2.31)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 8:19AM CDT

BIIB: 318.00 (-3.02), ROYL: 2.64 (-0.04), VMW: 86.06 (-0.44), OCN: 22.31 (-0.71), DDD: 33.06 (-1.44), AKRX: 37.50 (+2.07), BRCM: 42.22 (+1.07), ZAZA: 3.61 (+1.06), TKMR: 16.33 (+0.23), RPRX: 10.47 (+1.04), RGLS: 18.60 (-1.02), CLF: 10.63 (-0.08), LL: 54.26 (-0.34), LIVE: 3.58 (+0.06), YHOO: 50.09 (-0.51), GWPH: 75.25 (-0.07), ANGI: 6.02 (-0.27), XONE: 20.43 (+0.39), UIS: 27.34 (-0.56), IBIO: 1.11 (unch), SIX: 40.51 (-0.36), BBLU: 1.35 (+0.04), LPLA: 43.56 (+0.78), HIMX: 7.46 (+0.24), IRBT: 34.52 (-0.13), CREE: 35.62 (+0.74)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 85

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 207

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 79

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 378

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading

Top 5 Most Recently Viewed Articles

Boost Your Pup's Health with Routine and Technology

Updated Category News Views 121

Healthy Pet Routines Start with Pawfit Trackers As seasons change, it's a great opportunity to refresh not only our human routines but also those of our beloved pets. Pets thrive on consistency and routine, which contributes to their physical and mental well-being. Not only does implementing a structured schedule benefit pets, but it reinforces the bond we share with them...

Continue Reading
Revolutionizing Connectivity: World Mobile's Bold Move in Mozambique

Updated Category News Views 142

World Mobile’s Groundbreaking Initiative in Mozambique World Mobile, recognized as the sixth-largest blockchain-based connectivity company, has announced an important milestone by transitioning Mozambique's first national TV White Space (TVWS) spectrum database into the hands of local authorities, partnering with the Instituto Nacional de Comunicações de Moçambique...

Continue Reading
Ponce Bank Expands with New Coral Gables Office Offering Services

Updated Category News Views 167

Ponce Financial Group, Inc. opened its first representative office in Florida back in 2024, setting up shop at 1600 Ponce de Leon Drive in Coral Gables. This wasn't just a casual expansion; it marked a strategic move into a bustling Miami suburb packed with potential customers who either run businesses there or flock to the area during winter months. The whole idea was to...

Continue Reading
Cough Assist Devices Market Set for Expansive Growth Ahead

Updated Category News Views 150

Cough Assist Devices Market Analysis The cough assist devices market is poised for substantial growth, with projections indicating it could soar to USD 547.99 million in the upcoming years. This remarkable increase is expected to occur at a compound annual growth rate (CAGR) of 7.24% from its 2024 valuation of USD 275.99 million, as reported by a recent study from a...

Continue Reading
Transforming Futures Analysis with DOM Heatmap Integration

Updated Category News Views 189

Unveiling New Market Analysis Tools dxFeed, a frontrunner in market data solutions and index management, has partnered with ATAS to introduce a transformative approach to futures market analysis by offering historical DOM Levels, also known as Heatmap data. This innovative collaboration harnesses the power of historical order book liquidity data from major exchanges,...

Continue Reading